News for 'CEXI' - (Henry Ford Hospital Selects ValiMed From CDEX For Medication Validation; ValiMed Verifies Compounded Medications and Doses and Validates Narcotic Returns)
ROCKVILLE, Md. & DETROIT, Mar 16, 2006 (BUSINESS WIRE) -- Henry Ford Hospital
has selected the ValiMed system to perform end-product testing of compounded
intravenous medications in its pharmacy departments, and validation of returned
narcotics in its operating room suites and nursing units. The ValiMed medication
verification system was developed by CDEX (CEXI.OB) to give clinicians a quick,
cost effective, and simple tool to further ensure medication safety by verifying
medications are correctly compounded.
Henry Ford is a 903-bed tertiary care hospital, education and research complex
in Detroit. The hospital is recognized for clinical excellence and innovations
in the fields of cardiology and cardiovascular surgery, neurology and
neurosurgery, orthopaedics and rehabilitation, organ transplantation, and
treatment for prostate, breast and lung cancers, among others. Its Emergency
Department is a Level 1 trauma center. Henry Ford is the flagship hospital for
Henry Ford Health System, whose mission is to improve human life through
excellence in the science and art of health care and healing.
In a process that takes only seconds, ValiMed uses patent-pending technology to
validate compounded doses of high-risk medications prior to dispensing. The
solution creates an added level of safety in the medication dispensing process,
and is also used to validate narcotic returns as well as identify counterfeit
medications.
"At Henry Ford, our top priority is patient safety. The ValiMed product
strengthens our dispensing process by adding another level of safety to ensure
compounded medications are accurately verified and narcotic returns are properly
handled in the pharmacy," said Ed Szandzik, Director of Pharmacy at Henry Ford
Hospital.
"We are pleased to be working with Henry Ford Hospital, yet another nationally
recognized healthcare organization that has chosen to deploy ValiMed," said Jim
Griffin, CEO for CDEX. "Partners like Henry Ford are valuable as CDEX continues
its strategic growth in the healthcare sector."
The ValiMed by CDEX solution uses light energy and a library of unique spectral
fingerprints to validate drugs in solution. The device validates that the
correct drugs in the correct amounts have been added to the dose during the
compounding process.
About CDEX, Inc.
CDEX Inc. is a technology development company with a current focus on developing
and marketing products using chemical detection and validation technologies. At
present, CDEX is devoting its resources to two distinct areas: (i)
identification of substances of concern (e.g., explosives and illegal drugs for
homeland security); and (ii) validation of substances for anti-counterfeiting,
brand protection and quality assurance (e.g., validation of prescription
medication and detection of counterfeit or sub-par products for brand
protection). ValiMed is one line of CDEX products for the healthcare market.
CDEX is headquartered in Rockville, Maryland with its research and development
laboratory in Tucson, Arizona. For more information, visit www.cdex-inc.com and
www.valimed.com.
Any statements made in this press release which contain information that is not
historical are essentially forward-looking. Many forward-looking statements can
be identified by the use of words such as "expects," "plans," "may,"
"anticipates," "believes," "should," "intends," "estimates," and other words of
similar meaning. These statements are subject to risks and uncertainties that
cannot be predicted or quantified and, consequently, actual results may differ
materially from those expressed or implied by such forward-looking statements.
Such risks are detailed from time-to-time in filings with the Securities and
Exchange Commission. There is no obligation to publicly update any
forward-looking statements.
SOURCE: CDEX Inc.
CONTACT: CDEX, Inc.byWills & AssociatesBrad Wills, 301-767-1919bwills@wills-pr.com
Copyright Business Wire 2006
-0-
KEYWORD: United States
North America
Maryland
Michigan
INDUSTRY KEYWORD: Technology
Hardware
Software
Health
Biotechnology
Hospitals
Medical Devices
Pharmaceutical
Professional Services
Insurance
Legal
SUBJECT CODE: Contract/Agreement
Product/Service
AI
